FDA creates fast-track pipeline for gene therapies

This has already impacted dozens of gene-editing companies. This is (IMO) the new frontier of medicine - gene-editing sequences allows for individualized therapies. Over 30 million Americans suffer from "rare diseases" targeted by gene therapies. Future pathways for gene-editing are opened as well, allowing for possible in-utero editing. We're not there yet...but this is the first step in reducing headwinds.